Quotes 5-day view End-of-day quote Tokyo Stock Exchange
01/21/2021
01/22/2021
01/25/2021
01/26/2021
01/27/2021
Date
4150
4157
4193
4124
4237
Last
1842200
1751900
1589000
1774700
2582900
Volume
+2.39%
+0.17%
+0.87%
-1.65%
+2.74%
Change
Sales 2021
607 B
5 818 M
5 818 M
Net income 2021
70 626 M
677 M
677 M
Net Debt 2021
72 158 M
691 M
691 M
P/E ratio 2021
45,2x
Yield 2021
0,66%
Sales 2022
669 B
6 412 M
6 412 M
Net income 2022
91 777 M
879 M
879 M
Net Debt 2022
45 765 M
438 M
438 M
P/E ratio 2022
35,0x
Yield 2022
0,72%
Capitalization
3 201 B
30 761 M
30 671 M
EV / Sales 2021
5,39x
EV / Sales 2022
4,85x
Nbr of Employees
26 438
Free-Float
95,8%
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (55.7%);
- medical products for hospitals (27.2%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments...
Notations Surperformance© of Terumo Corporation
Trading Rating :
Investor Rating :
All news about TERUMO CORPORATION
News in other languages on TERUMO CORPORATION
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends TERUMO CORPORATION
Short Term Mid-Term Long Term Trends Neutral Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
14
Average target price
4 700,77 JPY
Last Close Price
4 237,00 JPY
Spread / Highest target
27,4%
Spread / Average Target
10,9%
Spread / Lowest Target
-10,3%
Please enable JavaScript in your browser's settings to use dynamic charts.